Brainstorm Cell Therapeutics Inc

NEW
OTCPK:BCLI (USA)  
$ 1.06 -0.020 (-1.85%) 09:30 AM EST
At Loss
Market Cap:
$ 11.70M
Enterprise V:
$ 13.17M
Volume:
1.56K
Avg Vol (2M):
20.84K
Trade In:
Volume:
1.56K
At Loss
Avg Vol (2M):
20.84K

Brainstorm Cell Therapeutics Inc (BCLI) Dividend

Brainstorm Cell Therapeutics Inc (BCLI) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -65.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: BCLI Dividend

Does Brainstorm Cell Therapeutics Inc (BCLI) pay a dividend?

Brainstorm Cell Therapeutics Inc (BCLI) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Brainstorm Cell Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Brainstorm Cell Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -65.2% over the past 3 years.

What are dividend-paying alternatives to Brainstorm Cell Therapeutics Inc?

For dividend-paying alternatives in Brainstorm Cell Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.